Table 2.
Laboratory data of AHF patients upon hospital admission.
| Alive (n = 197) |
Deceased (n = 118) |
All (n = 315) |
p-Value | |
|---|---|---|---|---|
| Albumin (g/L) | 38.2 (19.7–48.9) | 36.7 (21.8–56.5) | 37.8 (19.7–56.5) | 0.017 |
| AST (U/L) | 28.0 (10.0–1720.0) | 27.0 (6.0–1080.0) | 28.0 (6.0–1720.0) | 0.427 |
| ALT (U/L) | 25.0 (7.0–1082.0) | 21.0 (6.0–1168.0) | 25.0 (6.0–1168.0) | 0.031 |
| CK (U/L) | 105.0 (13.0–8135.0) | 78.0 (20.0–2414.0) | 93.0 (13.0–8135.0) | 0.198 |
| LDH (U/L) | 252.0 (119.0–3401.0) | 283.0 (111.0–2753.0) | 265.0 (111.0–3401.0) | 0.148 |
| BUN (mmol/L) | 8.3 (3.0–34.7) | 12.3 (3.1–32.2) | 9.6 (3.0–34.7) | <0.001 |
| Creatinine (µmol/L) | 107.0 (58.0–303.0) | 131.5 (59.0–366.0) | 117.0 (58.0–366.0) | <0.001 |
| eGFR (mL/min/1.73 m2) | 54.0 (12.1–103.5) | 38.4 (10.8–98.5) | 46.6 (10.8–103.5) | <0.001 |
| Sodium (mmol/L) | 140.0 (112.0–147.0) | 138.0 (122.0–148.0) | 140.0 (112.0–148.0) | <0.001 |
| Potassium (mmol/L) | 4.5 (3.2–6.3) | 4.5 (3.1–7.1) | 4.5 (3.1–7.1) | 0.091 |
| Chloride (mmol/L) | 104.0 (78.0–115.0) | 100.0 (82.0–112.0) | 103.0 (78.0–115.0) | <0.001 |
| hsTnI (ng/L) | 39.0 (10.0–50,000.0) | 61.0 (10.0–32,364.0) | 46.0 (10.0–50,000.0) | 0.898 |
| NT-proBNP (pg/mL) | 5350.0 (263.0–70,000.0) | 10,733.0 (226.0–70,000.0) | 6692.0 (226.0–70,000.0) | <0.001 |
| CRP (mg/L) | 10.3 (0.6–246.5) | 24.9 (0.7–240.0) | 12.2 (0.6–246.5) | <0.001 |
| IL-6 (pg/mL) | 22.1 (2.4–1848.0) | 40.6 (3.4–2800.0) | 25.1 (2.4–2800.0) | 0.136 |
| TC (mmol/L) | 3.8 (1.8–9.6) | 3.3 (1.6–8.0) | 3.5 (1.6–9.6) | <0.001 |
| HDL-C (mmol/L) | 1.1 (0.4–3.0) | 1.1 (0.2–2.5) | 1.1 (0.2–3.0) | 0.025 |
| LDL-C (mmol/L) | 2.0 (0.5–7.9) | 1.7 (0.6–5.9) | 1.9 (0.5–7.9) | <0.001 |
| Triglycerides (mmol/L) | 1.3 (0.6–8.9) | 1.3 (0.6–2.1) | 1.3 (0.6–8.9) | 0.064 |
| Erythrocytes (×1012/L) | 4.7 (3.3–6.3) | 4.4 (2.7–6.4) | 4.6 (2.7–6.4) | <0.001 |
| Hemoglobin (g/L) | 138.0 (93.0–185.0) | 126.0 (54.0–170.0) | 134.0 (54.0–185.0) | <0.001 |
| INR | 1.2 (0.8–5.3) | 1.3 (0.8–6.1) | 1.2 (0.8–6.1) | 0.077 |
Data are presented as median and minimum to maximum. Differences between AHF patients who were alive and those who died within 1 year after study inclusion were tested with the Mann–Whitney U test. p-values < 0.05 are considered significant and are depicted in bold. ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; CK, creatine kinase; CRP, C-reactive protein; eGFR, estimated glomerular filtration rate; hsTnI, high-sensitivity troponin I; HDL-C, high-density lipoprotein cholesterol; IL-6, interleukin-6; INR, international normalized ratio; LDH, lactate dehydrogenase; LDL-C, low-density lipoprotein cholesterol; NT-proBNP, N-terminal pro-brain natriuretic peptide; TC, total cholesterol.